Investigating the substrate specificity of the HER2/Neu tyrosine kinase using peptide libraries

Cancer Letters

Volumn 160, Issue 2, 2000, Pages 159-169

  Chan, Perry M ^a   Nestler, H Peter ^b   Miller, W Todd ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Simons Center for Quantitative Biology   (United States)

Author keywords

HER2 Neu; Peptide library; Substrate specificity; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; HER2 NEU TYROSINE KINASE; PEPTIDE LIBRARY; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BREAST CARCINOMA; CONTROLLED STUDY; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; NONHUMAN; ONCOGENE NEU; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; ANIMAL; BACULOVIRIDAE; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IRON CHELATING AGENTS; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; RECEPTOR, ERBB-2; SEQUENCE HOMOLOGY, AMINO ACID; SPODOPTERA; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; UNIDENTIFIED BACULOVIRUS;

EID: 0034727790     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00581-4     Document Type: Article

References (36)

1. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
2. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells
3. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
4. Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen
5. The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor
6. Involvement of pp60c-src with two major signaling pathways in human breast cancer
7. Biochemical comparisons of the normal and oncogenic forms of isect cell-expressed neu tyrosine kinases
8. Use of synthetic peptide libraries and phosphopeptide-selective mass spectrometry to probe protein kinase substrate specificity
9. Identifying substrate motifs of protein kinases by a random library approach
10. Use of an oriented peptide library to determine the optimal substrates of protein kinases
11. Amino-terminal sequence determinants for substrate recognition by platelet-derived growth factor receptor tyrosine kinase
12. Microautoradiographic identification of receptor-ligand interactions in bead-supported combinatorial libraries
13. The rapid identification of HIV protease inhibitors through the synthesis and screening of defined peptide mixtures
14. General method for rapid synthesis of multicomponent peptide mixtures
15. A new type of synthetic peptide library for identifying ligand-binding activity
16. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
17. Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator
18. Assay of protein kinases using peptides with basic residues for phosphocellulose binding
19. Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro
20. Role of enzyme-peptide substrate backbone hydrogen bonding in determining protein kinase substrate specificities
21. Characterization of pp60c-src tyrosine kinase activities using a continuous assay: Autoactivation of the enzyme is an intermolecular autophosphorylation process
22. A structural and kinetic comparison of proto-oncogenic and oncogenic neu holo-receptors expressed in insect cells
23. Catalytic specificity of protein-tyrosine kinases is critical for selective signaling
24. YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase
25. Selective adsorption of phosphoproteins on gel-immobilized ferric chelate
26. Two new criteria for choosing sample size in combinatorial chemistry
27. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
28. Identification of autophosphorylation sites of HER2/neu
29. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor
30. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer
31. The erbB-2 mitogenic signaling pathway: Tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency
32. The retinoblastoma gene product suppresses neu oncogene-induced transformation via transcriptional repression of neu
33. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence
34. Point mutation of the neu gene in rat neural tumor RT4-AC cells: Suppression of tumorigenicity by s-Myc
35. The neu-oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies
36. A time-efficient, linear-space local similarity algorithm